Phio Pharmaceuticals Corp. Profile Avatar - Palmy Investing

Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates…

Biotechnology
US, Marlborough [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Phio Pharmaceuticals Corp. (PHIO) to it's peer group.

Peer Group
EFTR ZURA AVRO CWBR ELEV IMMX APGN CDIO CNSP ZVSA OCEA SONN ATNF Compare Together
Loading...
End of PHIO's Analysis
CIK: 1533040 CUSIP: 71880W303 ISIN: US71880W4024 LEI: - UEI: -
Secondary Listings
PHIO has no secondary listings inside our databases.